VEGFR2/CD309 anticorps (Extracellular Domain)
-
- Antigène Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Épitope
- Extracellular Domain
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp VEGFR2/CD309 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Specificité
- Recognizes human VEGFR2.
- Purification
- Immunoaffinity purified
- Immunogène
-
Recombinant human extracellular domain of VEGFR-2 (KDR).
Type of Immunogen: Recombinant protein - Isotype
- IgG1
- Top Product
- Discover our top product VEGFR2 Anticorps primaire
-
-
- Indications d'application
-
Approved: IHC, IHC-Fr (1 - 2 μg/mL), IHC-P (1 - 2 μg/mL), WB (0.5 - 1 μg/mL)
Usage: Suitable for use in Western Blot and Immunohistochemistry. Western Blot: 0.5-1 μg/mL. Immunohistochemistry (paraffin, frozen): 1-2 μg/mL. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 1 mL sterile PBS
- Concentration
- Lot specific
- Buffer
- Lyophilized from 1.2 % sodium acetate, 2 mg BSA, 0.01 mg sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Aliquot to Avoid repeated freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
- Antigène
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Autre désignation
- KDR / VEGFR2 (VEGFR2 Produits)
- Synonymes
- anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl
- Sujet
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 - ID gène
- 3791
- UniProt
- P35968
- Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
-